Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells.
Barresi E, Baldanzi C, Roncetti M, Roggia M, Baglini E, Lepori I, Vitiello M, Salerno S, Tedeschi L, Da Settimo F, Cosconati S, Poliseno L, Taliani S. Barresi E, et al. Among authors: roggia m. Eur J Med Chem. 2023 Aug 5;256:115446. doi: 10.1016/j.ejmech.2023.115446. Epub 2023 May 7. Eur J Med Chem. 2023. PMID: 37182332 Free article.
Identification of Dual Inhibitors Targeting Main Protease (Mpro) and Cathepsin L as Potential Anti-SARS-CoV-2 Agents.
Previti S, Ettari R, Calcaterra E, Roggia M, Natale B, Weldert AC, Müller-Ruttloff C, Salisch F, Irto A, Cigala RM, Ziebuhr J, Schirmeister T, Cosconati S, Zappalà M. Previti S, et al. Among authors: roggia m. ACS Med Chem Lett. 2024 Mar 1;15(5):602-609. doi: 10.1021/acsmedchemlett.3c00562. eCollection 2024 May 9. ACS Med Chem Lett. 2024. PMID: 38746883
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites.
Trotta AM, Tomassi S, Di Maiolo G, Ieranò C, Vetrei C, D'Alterio C, Merlino F, Messere A, D'Aniello A, Del Bene A, Mazzarella V, Roggia M, Natale B, Cutolo R, Campagna E, Mottola S, Russo R, Chambery A, Benedetti R, Altucci L, Cosconati S, Scala S, Di Maro S. Trotta AM, et al. Among authors: roggia m. Eur J Med Chem. 2024 Oct 5;276:116669. doi: 10.1016/j.ejmech.2024.116669. Epub 2024 Jul 14. Eur J Med Chem. 2024. PMID: 39053189
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification.
Trotta AM, Mazzarella V, Roggia M, D'Aniello A, Del Bene A, Vetrei C, Di Maiolo G, Campagna E, Natale B, Rea G, Santagata S, D'Alterio C, Cutolo R, Mottola S, Merlino F, Benedetti R, Altucci L, Messere A, Cosconati S, Tomassi S, Scala S, Di Maro S. Trotta AM, et al. Among authors: roggia m. Eur J Med Chem. 2024 Dec 5;279:116911. doi: 10.1016/j.ejmech.2024.116911. Epub 2024 Sep 25. Eur J Med Chem. 2024. PMID: 39348763
Discovery of N-substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer.
Tomassi S, Natale B, Roggia M, Amato L, De Rosa C, Della Corte CM, Baglini E, Amendola G, Messere A, Di Maro S, Barresi E, Da Settimo F, Trincavelli ML, Ciardiello F, Taliani S, Morgillo F, Cosconati S. Tomassi S, et al. Among authors: roggia m. RSC Med Chem. 2024 Oct 3. doi: 10.1039/d4md00553h. Online ahead of print. RSC Med Chem. 2024. PMID: 39512947 Free PMC article.
Pursuing Polypharmacology: Benzothiopyranoindoles as G-Quadruplex Stabilizers and Topoisomerase I Inhibitors for Effective Anticancer Strategies.
Salerno S, Barresi E, Roggia M, Natale B, Marzano S, Hyeraci M, Reina SCR, Baglini E, Amato J, Salvati E, Dalla Via L, Da Settimo F, Cosconati S, Taliani S. Salerno S, et al. Among authors: roggia m. ACS Med Chem Lett. 2024 Oct 2;15(11):1875-1883. doi: 10.1021/acsmedchemlett.4c00313. eCollection 2024 Nov 14. ACS Med Chem Lett. 2024. PMID: 39563818
Reply: On the Need for Standardizing What We Actually Mean by ORA.
Goggin M, LaHood BR, Roggia MF, Chen TS, Beheregaray S, Esterman A. Goggin M, et al. Among authors: roggia mf. J Refract Surg. 2023 Feb;39(2):142-143. doi: 10.3928/01913913-20230111-01. Epub 2023 Feb 1. J Refract Surg. 2023. PMID: 36779467 Free article. No abstract available.
Reply: Non-lens ORA and Leftover Astigmatism Are the Same Entity.
Goggin M, LaHood BR, Roggia MF, Chen TS, Beheregaray S, Esterman A. Goggin M, et al. Among authors: roggia mf. J Refract Surg. 2022 Nov;38(11):748-749. doi: 10.3928/1081597X-20221025-02. Epub 2022 Nov 1. J Refract Surg. 2022. PMID: 36367267 Free article. No abstract available.
26 results